Upstream Bio Stock (NASDAQ: UPB) stock price, news, charts, stock research, profile.
You can purchase shares of Upstream Bio (NASDAQ:UPB) through any online brokerage.
Other companies in Upstream Bio’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
Upstream Bio has a consensus price target of $56.50.
The stock price for Upstream Bio (NASDAQ: UPB) is $16.2095 last updated December 20, 2024 at 4:14 PM EST.
There are no upcoming dividends for Upstream Bio.
Upstream Bio’s Q4 earnings are confirmed for Friday, February 14, 2025.
There is no upcoming split for Upstream Bio.
Upstream Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.